Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2014 2
2017 2
2018 2
2020 3
2021 3
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Conflict of Interest Disclosures.
[No authors listed] [No authors listed] Global Spine J. 2023 May;13(2_suppl):568S-591S. doi: 10.1177/21925682231173597. Global Spine J. 2023. PMID: 37222100 Free PMC article. No abstract available.
Predictors of outcome in the ISCHEMIA-CKD trial: Anatomy versus ischemia.
Bainey KR, Fleg JL, Hochman JS, Kunichoff DF, Anthopolos R, Chernyavskiy AM, Demkow M, Lopez-Quijano JM, Escobedo J, Poh KK, Ramos RB, Lima EG, Schuchlenz H, Ali ZA, Stone GW, Maron DJ, O'Brien SM, Spertus JA, Bangalore S. Bainey KR, et al. Am Heart J. 2022 Jan;243:187-200. doi: 10.1016/j.ahj.2021.09.008. Epub 2021 Sep 25. Am Heart J. 2022. PMID: 34582775 Free PMC article. Clinical Trial.
D/MI occurred in 104/307 participants (33.9%). Extent of CAD was associated with an increased risk of D/MI (P < .001), while ischemia severity was not (P = .249). ...CONCLUSION: Among ISCHEMIA-CKD participants randomized to the invasive strategy, extent of CAD pr …
D/MI occurred in 104/307 participants (33.9%). Extent of CAD was associated with an increased risk of D/MI (P < .001), whil …
National wastewater reconnaissance of artificial sweetener consumption and emission in Australia.
Li D, O'Brien JW, Tscharke BJ, Choi PM, Zheng Q, Ahmed F, Thompson J, Li J, Mueller JF, Sun H, Thomas KV. Li D, et al. Environ Int. 2020 Oct;143:105963. doi: 10.1016/j.envint.2020.105963. Epub 2020 Jul 17. Environ Int. 2020. PMID: 32688159 Free article.
Mean population-weighted per capita loads for individual artificial sweeteners (cyclamate, aspartame, acesulfame, sucralose, saccharin) ranged from 0.12 0.14 mg d(-1)p(-1) for aspartame to 6.9 2.8 mg d(-1)p(-1) for acesulfame with 1004 kg of these artificial sweeten …
Mean population-weighted per capita loads for individual artificial sweeteners (cyclamate, aspartame, acesulfame, sucralose, saccharin) rang …
Evaluating registry-based trial economics: Results from the STRESS clinical trial.
Eisenstein EL, Hill KD, Wood N, Kirchner JL, Anstrom KJ, Granger CB, Rao SV, Baldwin HS, Jacobs JP, Jacobs ML, Kannankeril PJ, Graham EM, O'Brien SM, Li JS. Eisenstein EL, et al. Contemp Clin Trials Commun. 2024 Jan 10;38:101257. doi: 10.1016/j.conctc.2024.101257. eCollection 2024 Apr. Contemp Clin Trials Commun. 2024. PMID: 38298917 Free PMC article.
Trends in artificial sweetener consumption: A 7-year wastewater-based epidemiology study in Queensland, Australia.
Li D, O'Brien JW, Tscharke BJ, Choi PM, Ahmed F, Thompson J, Mueller JF, Sun H, Thomas KV. Li D, et al. Sci Total Environ. 2021 Feb 1;754:142438. doi: 10.1016/j.scitotenv.2020.142438. Epub 2020 Sep 21. Sci Total Environ. 2021. PMID: 33254907
Population-weighted per capita mass loads of the four detected artificial sweeteners ranged from 2.4 0.8 mg d(-1) p(-1) for saccharin to 7.8 2.0 mg d(-1) p(-1) for acesulfame over the study period. ...
Population-weighted per capita mass loads of the four detected artificial sweeteners ranged from 2.4 0.8 mg d(-1) p(-1) for saccharin …
Mecamylamine treatment for alcohol dependence: a randomized controlled trial.
Petrakis IL, Ralevski E, Gueorguieva R, O'Malley SS, Arias A, Sevarino KA, Jane JS, O'Brien E, Krystal JH. Petrakis IL, et al. Addiction. 2018 Jan;113(1):6-14. doi: 10.1111/add.13943. Epub 2017 Oct 12. Addiction. 2018. PMID: 28710873 Free PMC article. Clinical Trial.
FINDINGS: There were no significant differences in the percentage of heavy drinking days at 3 months between the mecamylamine (mean = 18.4, SD = 29.0) and placebo treatment groups (mean = 20.4, SD = 29.2) [F(1, 100) = 1.3, P = 0.25; effect size d = 0.07; mean difference = …
FINDINGS: There were no significant differences in the percentage of heavy drinking days at 3 months between the mecamylamine (mean = 18.4, …
12 results